ationale and background
Treatment goals for patients with CMI are to reverse the
symptoms, facilitate weight gain, prevent the development of AMI, and improve the patient’s overall quality
of life. The optimal treatment represents a balance between the natural history of the underlying disease process and the risks associated with the speciﬁc
treatment. Unfortunately, the natural history of both
CMI and MAOD remain poorly deﬁned, although the potential adverse sequelae are well-known. Accordingly